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Background 
 
There are an extensive number of published evidence reviews examining the influence of lifestyle 
behaviours on cancer outcomes. Healthy lifestyles are a significant topic of debate in oncology and in 
policy and practice organisations that support people living with and beyond cancer. Such reviews 
vary in quality, address different relationships, outcomes and cancers, and there is often more than 
one review on important topics. This makes it difficult for policy and practice professionals to make 
decisions about the prescription and promotion of lifestyle behaviours for cancer populations. An 
overview of systematic reviews provides a single, overarching summary of evidence from published 
systematic reviews and compares and contrasts the findings of systematic reviews, providing 
healthcare professionals with the evidence needed for more effective decision making (Smith et al. 
2011). This overview of systematic reviews synthesises evidence from systematic reviews on smoking, 
physical activity, dietary behaviours and alcohol consumption to present a summary of evidence about 
the relationships between these lifestyle behaviours and outcomes for people living with and beyond 
cancer. 
 
Protocol registration 
The protocol for this review was registered on the PROSPERO International Prospective Register of 
Systematic Reviews (Registration number CRD42016032857). 
 
Methodology 
Aim  
 
To synthesise the findings of an overview of systematic reviews that investigated the relationship 
between healthy lifestyle behaviours on outcomes for people living with and beyond cancer. 
 
Criteria for considering reviews for inclusion   
Types of studies 
We included systematic reviews that assessed the relationship between healthy lifestyle behaviours 
and outcomes in people living with and beyond cancer. This included reviews of non-randomised 
observational studies including cross-sectional, prospective cohort and case-control studies. To be 
included any review must have achieved a judgement of "Yes" on the third criterion on the AMSTAR 
tool for assessing the quality of systematic reviews (Shea 2007): "Was a comprehensive literature 
search performed?" as we considered this a minimum requirement for a review to be deemed 
systematic. Our additional criteria for considering a search to be systematic were that authors must 
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have searched at least 2 electronic databases using a clear search strategy, and screened the reference 
lists of identified studies. We excluded reviews published prior to 2010. We only included reviews 
published in the English language. 
Types of participants 
Adults, 18 years or older living with or beyond cancer. This included any group who had received a 
cancer diagnosis for any cancer type, at any stage in the treatment or recovery pathway. We did not 
consider evidence relating to the risk of incident primary cancer diagnoses. That is, we were interested 
in the influence of healthy lifestyle behaviours on outcomes for people living with and beyond cancer, 
not as risk factors for primary cancer. 
Types of behaviour 
Any behaviour commonly associated with a healthy or unhealthy lifestyle. This included participation 
in exercise and exertional physical activity, dietary choices, tobacco use and consumption of alcohol. 
Obesity and BMI were also included as variables of interest related to dietary behaviours. While we 
recognise that obesity and BMI are not lifestyle choices per se they were considered as variables 
partially related to lifestyle behaviours. 
Types of outcome measure 
We included reviews that measured the following core cancer outcomes: 
 Mortality 
 Recurrence 
 Remission/ recovery 
 Disease progression 
 Late effects and Consequences of Treatment (incidence or severity of any known consequence 
of cancer treatment) 
and/ or measures of physical health or wellness which could include physical function, quality of life, 
wellbeing, fatigue, anxiety and depression. 
 
Search methods for identification of reviews   
Electronic searches 
Electronic databases were searched using a combination of controlled vocabulary (MeSH) and free 
text terms from 2010 to Jan 2016. Search terms were incorporated to target cancer and systematic 
reviews. We incorporated the BMJ Clinical Evidence search filter for systematic reviews. The OVID 
MEDLINE search strategy can be found in Appendix A. All database searches were based on this 
strategy but appropriately revised to suit each database. The following databases were searched: 
 Cochrane Database of Systematic reviews 
 Centre for Reviews and Dissemination 
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 OVID MEDLINE 
 EMBASE 
 CINAHL plus 
 
Searching other sources 
The reference lists of all eligible reviews were hand-searched to attempt to identify additional relevant 
reviews.  
 
Identification of reviews 
Search results were independently checked by two overview authors and eligible reviews were 
included. Initially the titles and abstracts of identified studies were reviewed. Where it was clear from 
the title that the study did not meet the inclusion criteria it was excluded. Where it was not clear from 
the title and abstract whether a study was relevant the full review was checked to confirm eligibility. 
The selection criteria were then independently applied to the full papers of identified reviews by two 
overview authors. Where two independent reviewers did not agree in their primary judgements they 
discussed the conflict and attempted to reach a consensus. If this was not successful a third member 
of the review team considered the title and a majority decision was made. 
 
Data collection and analysis   
Data extraction and management   
Data were extracted independently by two overview authors using a standardised form. Discrepancies 
were resolved by consensus. Where agreement could not be reached a third overview author 
considered the paper and a majority decision was reached. The data extraction included the following 
details: 
 the assessment of methodological quality of the included review 
 the objectives of the review 
 details of the included participants 
 the exposures (healthy lifestyle behaviours) studied, including detail where available on the 
measurements used and the severity or amount of exposure 
 the outcomes and time-points assessed (primary and secondary) and estimates of association 
(effect size) with measures of imprecision at all time-points available 
 The assessment of the methodological quality/ risk of bias of the included studies and 
judgements of the quality of the body of evidence (for example using GRADE) 
 The presence of possible conflicts of interest for authors of the included trials within a review, 
and for the authors of the review themselves 
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We did not seek information from the included clinical trials that is not presented in the identified 
reviews. 
 
Assessment of methodological quality of included reviews   
We used the AMSTAR tool to assess the methodological quality of the included reviews (Shea 2007) 
(see Appendix B for an example of the tool) 
 
Assessment of the quality of the evidence in included reviews 
We expected that included reviews are likely to have assessed the methodological quality/risk of bias 
of included studies in a variety of ways. We used the judgements made by the authors of original 
reviews regarding the quality of evidence/risk of bias but have reported it within the context of our 
assessment of the quality of the review itself.  
 
Data synthesis   
We tabulated summaries of the characteristics of the included reviews. The precise comparisons 
presented were primarily determined by the content of the included reviews. We have presented 
effect sizes using appropriate metrics including estimates of precision where available.  Data were 
grouped where possible according to diagnosis (cancer type), stage in the cancer journey (during 
treatment, after treatment, advanced cancer), the type of exposure (exercise/ physical fitness, 
smoking behaviour, drinking behaviour, healthy eating/ dietary behaviours, general healthy lifestyle 
behaviours) and outcome. Important limitations within the evidence base are presented and 
discussed. We considered the possible influence of publication/small study biases on review findings. 
Where included reviews did not rate the quality of the body of evidence we applied, where possible, 
the GRADE approach for all key comparisons (Guyatt et al. 2008). In the GRADE approach evidence 
from non-randomised studies is rated as low. Ratings can be further downgraded where there is 
concern over the limitations of the included studies, imprecision in observed effects, inconsistency, 
and indirectness of the evidence to the population of interest or evidence of publication bias. Ratings 
can be upgraded where there is consistent evidence of large effects, or other indicators that increase 
confidence in an estimate such as evidence of a dose-response relationship. Ratings can be high, 
moderate, low or very low quality. In terms of confidence in the findings the ratings can be defined as 
follows: 
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the 
estimate of effect and may change the estimate. 
Low quality: Further research is very likely to have an important impact on our confidence in the 
estimate of effect and is likely to change the estimate. 
Very low quality: We are very uncertain about the estimate. 
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FINDINGS 
 
Results of the searches 
After removal of duplicates the electronic searches returned 6404 records for screening. Of these 120 
were retained after abstract and title screening and the full texts were assessed. 93 records were 
excluded at this stage and 3 further relevant reviews were identified through hand-searching of the 
reference lists of included reviews, resulting in 30 reviews in total included in this overview. The search 
screening process is illustrated in Figure 1. See Appendix 2 for a list of excluded studies with reasons 
for exclusion. 
 
Characteristics of Included Reviews 
The included reviews investigated the relationships of a range of lifestyle behaviours for a broad range 
of different cancer types and stages if disease. For a summary of the characteristics of the included 
reviews see Table 1.  
Nine reviews (Cao et al. 2011, Chi et al. 2013, Davies et al. 2011, Lee et al. 2015, Koutoukidis et al. 
2015, Ogunleye et al. 2010, Smits et al. 2015, Xing et al. 2014, Zhang et al. 2013) investigated the 
influence of dietary behaviours and/ or obesity on outcomes of interest. Nine reviews (Barbaric et al. 
2010, Davies et al. 2011, Fontein et al. 2013, Henneghan et al. 2016, Ibrahim et al. 2011, Kim et al. 
2013, Koutoukidis et al. 2015, Lahart et al. 2015, Zhong et al. 2014)  investigated the relationship 
between physical activity and exercise behaviours on relevant outcomes. Nine reviews investigated  
smoking behaviours (Braithewaite et al. 2012, Crivelli et al. 2014,Florou et al. 2014, Pang et al. 2015, 
Parsons et al. 2014,  Rowland et al. 2012, Walter et  al. 2014, Xu et al. 2014, Zhang et al. 2013) and 
two reviews investigated alcohol consumption (Druesne-Pecollo et al.2014, Gou et al. 2013). 
Outcomes measured, relevant to this overview, included survival and mortality (all-cause or cancer 
specific), recurrence, disease progression, quality of life, cancer treatment related complications and 
cognitive dysfunction. All of the included evidence included in this overview related to people 
following diagnosis of cancer but few reviews specifically focused on people at a specific stage of their 
cancer journey. 
 
Quality of Included Reviews 
The AMSTAR quality assessment scores for the included reviews ranged from 2 to 7 out of a maximum 
of 11 (median 4). It was not clear for any of the reviews whether an a priori protocol was used in the 
conduct of the review and none of the reviews appeared to have been pre-registered on PROSPERO. 
Only 2 reviews searched for grey literature and included studies regardless of language, and only 3 
reviews presented a full list of excluded studies. Notable, of 30 reviews 19 did not report a formal 
assessment of the quality of included studies, something we consider a major flaw. The possibility of 
publication bias was commonly not considered in the included reviews. The full results for the AMSTAR 
quality assessment are presented in table 2. 
 
 Evidence review: lifestyle behaviours and outcomes for people living with and beyond cancer 
 
 
8 
 
R
E
SU
L
T
S 
O
F
 T
H
E
 S
E
A
R
C
H
E
S 
 
Figure 1: PRISMA flow diagram of the search screening process 
 
 
 
 
 
 
 
 
 
 
 
Records identified through database searching 
n=9009 
Records after 2605 duplicates removed 
n =6404 
Records screened 
n = 6404 
Records excluded on basis of title 
and abstract and removal of 
conference abstracts n=6284  
Full-text articles assessed for 
eligibility 
n = 120 
Full-text articles excluded n=93 
Reasons for exclusion 
Not in English = 1 
Not a systematic review= 49 
Not specific to population of 
interest =22 
Does not include lifestyle 
behaviours=7 
Does not include outcomes of 
interest = 4  
Review of interventions = 10 
 
Reviews identified through hand-
searching reference lists n=3 
Reviews included in synthesis n = 30 
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Table 1. Characteristics of included reviews 
Review  Search 
dates (to) 
Participants or 
cancer type* 
Behaviour 
related factors* 
Outcomes* N of studies/participants* 
Design of included studies 
Study quality tool used. 
 
Barbaric 2010 1950-2008 Patients with breast, 
colorectal or colon 
cancer 
PA Primary outcome = 
survival; secondary 
outcomes = cancer-
specific and overall 
mortality 
10 prospective cohort 
studies,  N= 13824 
PEDro scale for RCTs  
Newcastle-Ottawa Scale 
(NOS) 
Braithewaite 
2012 
July 2012 Adult Women with 
invasive breast 
cancer 
Smoking Mortality 7 cohort studies, N=>14,000 No formal assessment of 
study quality 
Cao 2011 Jan 2010 Men diagnosed 
with prostate 
cancer. 
BMI Prostate Ca specific 
mortality 
Biochemical recurrence 
22 studies, Prospective, and 
retrospective 
Mortality N=18203 
Recurrence N=26479 
 
No formal assessment of 
study quality 
Chi 2013 Jan 2013 People with abreast 
cancer diagnosis 
Soy intake Mortality (? All-cause 
or Ca-specific) 
Recurrence 
5 studies 
All prospective 
N= 11224 
No formal assessment of 
study quality 
Crivelli 2014 July 2012 Patients with 
urothelial cancer of 
the bladder or upper 
tract urothelial 
cancer treated with 
surgery 
Smoking Recurrence, 
progression,  
cancer-specific 
mortality,  
all-cause mortality 
29 studies, designs unclear. 
N=15,116 
No formal assessment of 
study quality 
Davies 2011 Aug 2011  Breast, prostrate, 
colorectal survivors 
PA and diet Recurrence and 
progression 
14 studies on diet (1 
colorectal, 5 prostate, 8 
breast) – RCTs, longitudinal 
studies, prospective cohort, 
cohort, retrospective, review 
of epidemiology literature, 
interview study 
14 studies on PA (9 breast, , 
3 colorectal, , 2 prostate)  
N = 121, 845  
No formal assessment of 
study quality 
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Druesne-Pecollo 
2014 
July 2012 Adults with upper 
aerodigestive tract 
(UADT) as first 
primary cancer site 
Alcohol 
consumption 
Second primary cancer 
risk 
19 studies 
8 cohort studies; 
11 case-control studies 
N= not reported 
No formal assessment of 
study quality 
Florou 2014 July 2013 Adults with any 
cancer type 
Smoking Overall survival, 
Progression-free 
survival, 
Recurrence-free 
survival,  
Mortality,  
Recurrence, 
Progression,  
Quality of life  
Performance status 
response to therapy, 
risk for second cancer,  
risk for second primary 
tumour,  
20 studies, 
4 retrospective, 15 
prospective observational, 3 
RCTs 
N=12,725 
No formal assessment of 
study quality 
Fontein 2013 November 
2012. 
Breast cancer 
patients 
PA Survival outcomes 
All-cause mortality 
Breast cancer specific 
mortality 
N = 35,026 No formal assessment of 
study quality 
 
Gou 2013 February 
2013 
Breast 
cancer patients 
Alcohol 
consumption 
Survival 25 prospective cohort 
studies. N=719555 
No formal assessment of 
study quality 
Henneghan 2016 June 2015 Breast cancer 
survivors 
PA Cancer related 
cognitive impairment 
2 cross sectional studies 
N=55 
 
9 point quality scale, results 
not reported. 
Ibrahim 2011 Not stated  Breast cancer 
patients 
PA Breast cancer outcomes 
Breast cancer mortality 
All cause mortality 
6 studies 
4 observational (2 
prospective),  
1 interview study  
1 population-based case 
control study 
 
N =12,108 
 
No formal assessment of 
study quality 
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Jansen 2010 January 
2010 
Colorectal cancer 
survivors 
BMI Quality of Life One study, design not 
reported 
259 participants 
Mols 14-item standardised 
checklist  
Kayani 2012 January 
2012 
Esophageal cancer 
post-
oesophagectomy 
BMI Successful tumour 
resection 
Complications 
Reoperation rate 
Mortality and long-
term survival 
5 retrospective cohort 
studies 
N=1682 
No formal assessment of 
study quality 
Kim 2013 May2013 Breast cancer over 
18 years 
PA Breast cancer mortality 
risk 
 
breast cancer mortality risk 
total N= 35, 504 
physiological functions 
N = 1027  
No formal assessment of 
study quality 
 
Koutoukidis 2015 January 
2014 
Endometrial cancer 
survivors 
stages I-IV 
Obesity 
Diet 
Physical activity 
HRQoL 
 
Adherence to physical 
activity guidelines 
8 studies, 6 relevant to 
review 
4 cross-sectional 
1 retrospective 
1 prospective 
n of participants for all 
studies not reported 
SIGN checklists 
0 high quality studies 
2 acceptable quality 2 
unacceptable quality 
Lahart 2015  October 
2014,  
 
Breast cancer 
survivors 
PA breast cancer outcomes 
(i.e. breast cancer-
related deaths or 
recurrences).  
average follow-up 
periods ranging from 
4.3 to 12.7 years 
Twenty-two prospective 
cohort studies 
123 574 participants  
 
The Newcastle-Ottawa scale 
was used to critically 
appraise the risk of bias 
across studies.  
  
 
Lee 2015 September 
2014 
Patients with 
colorectal cancer 
BMI colorectal cancer-
specific mortality 
 all-cause mortality 
16 studies 
14 prospective 
2 case-control 
n= 58,917 
The Newcastle-Ottawa Scale 
(NOS) 
Results not reported 
Ogunleye 2010 December  
2008 
Breast cancer Green tea 
consumption 
Breast cancer 
recurrence 
2 studies, both prospective 
cohort. 
n=1588 
No formal assessment of 
study quality 
Pang 2015 September 
2014 
People with liver 
cancer 
Smoking Mortality, Recurrence 4 Cohort studies 
n= 1031 
Newcastle-Ottawa scale. 
Studies scored between 6-
8/9 
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Parsons 2010 December 
2008 
Lung cancer, any 
type or stage. 
Smoking 
cessation 
All-cause mortality, 
Second primary cancer 
Recurrence 
10 observational studies, 4 
prospective, 5 retrospective, 
1 unclear. 
N=1929 
Altman criteria for 
prognostic studies 
Rowland 2012 June 2010 Adults with a lung 
cancer 
diagnosis 
Smoking  HRQoL 8 studies 
5 cross-sectional 
3 longitudinal 
N=2100 
CASP appraisal tool 
Smits 2015 October 
2014 
Endometrial cancer 
survivors 
BMI Quality of life 
Anxiety and depression 
Sexual function 
7 studies 
Cross sectional, 
retrospective, prospective 
n=1774 
 
Cochrane Non-Randomised 
Studies Methods Group tool. 
All studies at high risk of 
bias on more than one 
criteria 
So 2012 December 
2011 
Head and neck 
cancer survivors 
Smoking  Quality of Life One prospective longitudinal 
study. 
N=316 
Mols 14-item standardised 
checklist 
Walter 2014 August 2013 People with 
colorectal cancer 
Smoking Recurrence-free 
survival, 
Disease-free survival, 
All-cause mortality 
Colorectal cancer 
mortality 
16 studies 
Designs not reported 
N=62,278 
4 point tool based on 
MOOSE checklist 
Xing 2014 August 2013 Women with breast 
cancer 
Low fat diet Breast cancer specific 
mortality 
 
All-cause mortality 
1 cohort study 
N=4441 (USA) 
2 RCTs  
Pooled n= 9966 
No formal assessment of 
study quality 
Xu 2014 November 
2013 
People with renal 
cell carcinoma 
Smoking Overall mortality, 
Disease specific 
mortality,  
Overall survival, 
Cancer specific 
survival progression 
free survival 
14 studies, designs not 
reported. 
N=343,993 
Newcastle Ottawa. 
Zhang 2013 December 
2012 
People who 
underwent surgery 
for oesophageal 
cancer 
BMI Postoperative 
complications 
Survival 
14 studies 
Designs not clear 
n=2031 
No formal assessment of 
study quality  
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Zhang 2015 Not reported NSCLC patients 
with EGFR 
mutations after 
EGFR-TKI treat- 
ment that were not 
used as combined 
therapy or 
maintenance 
therapy 
Smoking Progression free 
survival 
9 studies 
2 prospective, 7 
retrospective. 
N=1029 
Quorum and the Cochrane 
Collaboration guidelines. 
Results not reported. 
Zhong 2014  People with breast 
cancer 
PA All-cause mortality and 
breast cancer specific 
mortality 
16  
cohort studies involving N = 
42,602  
No formal assessment of 
study quality  
*Relevant to this overview   **Conclusions of authors of the included review 
 
Abbreviations 
a/w    associated with 
CASP    Critical Skills Appraisal Programme  
EGFR    Epidermal growth factor receptor 
HR-QoL   Health Related Quality of Life 
MOOSE   Meta-analysis Of Observational Studies in Epidemiology 
NSCLC    Non-small cell lung carcinoma 
SIGN    Scottish Intercollegiate Guidelines Network 
TKI    Tyrosine-kinase inhibitors 
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Table 2. AMSTAR scoring results for all included reviews 
 
REVIEW 1.  
a 
priori 
design
? 
2.  
duplicate 
selection 
& 
extraction
? 
3. 
comprehen-
sive search? 
4.  
Incl. grey 
lit and 
language
? 
5.  
List of 
studies 
incl/excl 
6. 
characteris-
tics of 
studies 
presented? 
7.  
quality 
assessed 
and 
reported? 
8.  
Quality 
used 
approp-
riately 
9.  
pooling 
approp-
riate? 
10. 
publicatio
n  bias 
assessed? 
11.  
CoI 
stated? 
 
Overall 
SCORE 
/11 
Barbaric 2010 CA Y N N Y Y Y Y CA N N 5 
Braithewaite 
2012 
CA N Y N N Y N CA NA N N 3 
Cao 2011 CA Y Y N N Y N N Y Y N 5 
Chi 2013 CA Y Y N N Y N N Y Y N 5 
Crivelli 2014 CA Y Y N N Y CA CA NA N N 4 
Davies 2011 CA Y N N N Y N N N N N 2 
Druesne-
Pecollo 2014 
CA Y Y Y N Y N N Y Y N 6 
Florou 2014 CA N Y N N Y N CA NA N N 3 
Fontein 2013 CA Y N N N Y N N NA N N 3 
Gou 2013 CA Y Y N N Y N N Y Y N 5 
Henneghan 
2016 
CA N Y N N Y Y CA NA N N 4 
Ibrahim 2011 CA CA Y N N Y CA CA Y Y N 4 
Jansen  2010 CA N Y N N Y Y N NA N N 4 
Kayani 2012 CA N Y N N Y N N Y Y N 4 
Kim 2013 CA Y N N N Y N N NA N N 3 
Koutoukidis 
2015 
CA Y Y Y N Y Y N NA N N 6 
Lahart 2015 CA Y Y N N Y Y Y Y Y N 7 
Lee 2015 CA Y Y N N Y Y N Y Y N 6 
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Ogunleye 2010 CA N Y N N Y N N NA Y N 4 
Pang 2015  CA Y Y N Y Y Y N Y Y N 7 
Parsons 2010 CA Y Y Y N Y Y CA Y N N 6 
Rowland 2012 CA Y Y N N Y Y CA NA N N 5 
Smits 2015 CA N Y CA N Y Y Y CA N N 4 
So  2012 CA N Y N N Y Y N NA N N 4 
Walter 2014 CA Y Y N Y Y Y CA Y CA N 6 
Xing 2014 CA CA Y N N Y N N Y N N 3 
Xu  2014 CA Y Y N N Y Y CA Y N N 5 
Zhang 2013 CA N N N N Y N N Y Y N 3 
Zhang 2015 CA Y Y Y N N N CA Y CA N 4 
Zhong 2014 CA Y Y N N Y Y Y Y Y N 7 
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Findings of included reviews 
 
DIETARY BEHAVIOURS AND OBESITY 
 
Breast cancer 
Green tea consumption 
Outcome: Recurrence 
One review (Ogunleye et al. 2010) investigated the association between green tea consumption and 
breast cancer risk. Relevant to this overview it included the outcome of recurrence of breast cancer. 
For this outcome the review identified two prospective cohort studies conducted in Japan, including 
1,588 participants in total. The review presented no formal quality assessment for the included 
studies. Pooling of these studies resulted in a marginally statistically significant 27% reduction in the 
relative risk (RR) of breast cancer recurrence (RR 0.73 95%CI 0.56-0.956) among “heavy” green tea 
drinkers compared to non-drinkers with no heterogeneity. The duration of follow up and degree of 
attrition of both studies was not reported in this review. The authors of the review concluded that the 
data provide preliminary evidence for a benefit of green tea consumption in preventing recurrence.  
The AMSTAR quality score for this review was  4/11. 
Given the lack of information regarding study quality, length of follow up and the fact that both studies 
were conducted in Japan (raising issues of generalisability and directness given likely differences in 
environment and average diet compared with the UK)the GRADE level of evidence for this association 
was rated as very low (downgraded for limitations and indirectness). 
 
Soy intake 
Outcome: mortality and recurrence 
One review (Chi et al 2013) investigated whether soy intake was associated with breast cancer survival 
or recurrence after diagnosis. This review included five cohort studies, three from China and two from 
the USA which included a combined 11,224 participants. The studies all recruited participants 
following breast cancer diagnosis and follow-up duration was between 3.9 to 7.3 years. Soy intake was 
measured in grams per day. The review presented no formal quality assessment for the included 
studies.  The AMSTAR score for this review was 5/11. 
For mortality the review found a statistically significant 15% reduction either when all doses of soy 
were compared to the lowest dose (5 studies, n for comparison not reported, Hazard Ratio HR 0.85, 
05%CI 0.77 to 0.93), or when the highest dose was compared with the lowest dose (5 studies, n for 
comparison not reported, HR 0.84, 95%CI 0.71 to 0.99) with no significant heterogeneity.  
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For recurrence similar reductions were observed (4 studies, n for comparison not reported, all doses 
vs highest dose HR 0.79, 95%CI 0.72 to 0.87; highest vs lowest dose HR 0.74, 95%CI 0.64 TO 0.85). On 
a secondary analysis this review found that these associations were not statistically significant in 
patients taking tamoxifen. Subgroup analyses found  that association between soy intake and 
mortality was unchanged by menopausal status or the estrogen receptor (ER) status of the cancer but 
that soy food intake was associated with lower recurrence in ER negative, ER+/progesterone receptor 
(PR)+, and postmenopausal patients. 
The review authors conclude that soy intake might be associated with lower mortality and recurrence. 
Given the lack of information regarding study quality, the GRADE level of evidence for this association 
was rated as very low (downgraded for limitations). 
 
Low fat diet 
Outcome mortality 
One review (Xing et al. 2014) aimed to investigate the effect of a low fat diet post breast cancer 
diagnosis on recurrence and all-cause mortality. Relevant to this overview they included one multi-
centre cohort study of 4441 participants, conducted in the USA with an average 5.5 year follow up 
period. No formal quality assessment of included studies was presented in this review and the cohort 
study investigated survival but not recurrence. The AMSTAR score for this review was 3/11. 
The cohort study found no statistically significant effect of low fat diet on all-cause mortality in people 
following breast cancer diagnosis (HR 0.89 (95%CI 0.65-1.21). When data from that study was pooled 
with the results of 2 RCTs, also conducted in the USA of low fat diet interventions post diagnosis (not 
strictly relevant to this review) the effect remained statistically non-significant (HR 0.83, 95%CI 0.69-
1.0, P=0.05, pooled n= 9966) with no significant heterogeneity. The authors of the review concluded 
that more evidence was needed to evaluate the effect of a low fat diet on all-cause mortality following 
breast cancer. Given the lack of clarity on study quality, the low AMSTAR score of the review, and the 
fact that the estimate of the pooled effect came close to the threshold for statistical significance the 
GRADE level of evidence was rated as of very low quality(downgraded for limitations and imprecision) 
for no association between low fat diet and all-cause mortality in people following breast cancer 
diagnosis.  
 
Endometrial cancer 
BMI and diet 
Outcome: QoL (Quality of Life) 
Two reviews (Koutoukidis et al. 2015; Smits et al 2015) aimed to explore the relationships between 
obesity and/ or diet with HRQoL in survivors of endometrial cancer.  
Koutoukidis et al. (2015) identified 8 studies of which 2 were RCTs and not relevant to this review. The 
review included studies of survivors of stage I-IV endometrial cancers. Survivorship was defined as 
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those surviving at the end of primary or adjuvant therapy, with or without disease. The review only 
reported the characteristics of 4 of the 6 relevant studies, 3 of which were cross-sectional and one a 
retrospective study. Study quality was assessed using the Scottish Intercollegiate Guidelines Network 
(SIGN) checklists. 2 studies were rated as of acceptable quality, 2 as of unacceptable quality. No studies 
were rated as high quality. The AMSTAR score for this review was 6/11. 
No meta-analysis was conducted in this review.  Of three studies (combined n =1212) that assessed 
the relationship between BMI and HRQoL all showed  improved HRQoL with BMI, with standardised 
effect sizes (Cohen’s d)ranging between small (≥0.2) and large (≥0.8) effects. 
One study (n= 729) showed an improved general HRQoL with lower BMI and increased physical activity 
after adjusting for major confounders. 
The authors conclude that a healthy lifestyle is positively associated with HRQoL in this population, 
but the number and quality of studies is limited.  
Smits et al. (2015) included HRQoL but also anxiety, depression and sexual function as outcomes. They 
included seven studies of 1,744 adult women who had completed treatment for endometrial cancer. 
Studies had a mix of cross-sectional, retrospective and prospective designs of which four studies (3 
cross-sectional and 1 retrospective, n=1362) were included in meta-analyses.  3 of these studies were 
included in the review of Koutoukidis. Risk of bias of the included studies was assessed using the 
Cochrane non-Randomised Studies Methods Group tool. All studies were judged as at high risk of bias 
on more than one criteria. The AMSTAR score for this review was 4/11. 
The analyses suggested that obese survivors had significantly poorer physical functioning (4 studies, 
pooled n=1235, mean difference (MD) −11.61, 95% CI −18.66 to −4.55, p=0.001), social functioning (2 
studies, pooled n= 797, MD −4.37, 95% CI: −7.75 to −1.00, p=0.01) and role functioning (3 studies, 
pooled n=693, MD −5.44 95% CI: −8.90 to −1.98, p=0.002) when compared to non-obese women. 
Emotional functioning and cognitive functioning did not show significant differences. 
For sexual function one study of 666 patients showed an inverse relationship with a higher BMI 
associated with less sexual/vaginal problems and this persisted after adjustment for patient 
characteristics. Sexual interest and enjoyment were not associated with BMI.  
The review found no studies that investigated the relationship between anxiety and depression and 
BMI in this population.  
The GRADE level of evidence for the association between obesity and the various QoL domains is very 
low (downgrade for limitations of studies). The level of evidence for sexual function relationships is 
very low (downgrade for limitations of studies and imprecision (single study only).  
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Prostate Cancer 
BMI 
Outcome: mortality and recurrence 
One review (Cao et al. 2011) investigated the associations between BMI and risk of dying from prostate 
cancer. Relevant to this Overview they conducted an analysis of this relationship in people post-
diagnosis and an analysis of the association between BMI and biochemical recurrence of cancer.  The 
review reported no formal quality assessment of the included studies and was rated at 5/10 on the 
AMSTAR scale. 
This review included six studies including 18,203 participants that evaluated the association between 
BMI and prostate cancer-specific mortality. Follow-up ranged from 4 to >7 years.  In a meta-analysis 
of these studies there was a 20% higher relative risk for every 5kg/m2 increase in BMI (Risk Ratio (RR) 
1.20, 95%ci 0.99-1.46), though this did not meet statistical significance (p=0.06). There was high 
heterogeneity between the studies. No publication bias was observed. 
This review included 16 studies including 26,479 participants that assessed the relationship between 
BMI and biochemical recurrence. Follow-up ranged from 2 to 10 years. Meta-analysis of these studies 
found an 21% increase in the relative  risk of recurrence (RR 1.21, 95%ci 1.11-1.31). Heterogeneity was 
again high and asymmetric funnel plots suggested the presence of possible publication bias. 
The authors conclude that higher BMI is associated with higher mortality in people post-diagnosis of 
prostate cancer and higher risk of recurrence following primary treatment.  The GRADE level of 
evidence for the association between BMI and mortality is very low (downgraded for limitations due 
to the lack of quality assessment, imprecision due to non-significance and inconsistency due to the 
high heterogeneity). For the association between BMI and recurrence the level of evidence is also very 
low (downgraded for limitations, inconsistency and possible publication bias). 
 
Oesophageal cancer 
BMI 
Outcomes: post-operative complications and mortality 
2 reviews (Kayani et al. 2012, Zhang et al. 2013) reviewed studies of the association between BMI, 
post-operative complications and survival in people who had undergone surgery for oesophageal 
cancer.  
Zhang included 14 studies in total with 2031 participants. The design on the included studies was not 
clearly reported. The review reported no formal assessment of study quality. The AMSTAR score for 
this review was 4/11. 
Meta-analysis found  very small increases in the relative riskof post-operative complications in the 
highest compared to the lowest BMI group for anastomotic leakage (RR 1.04, 95%CI 1.02 to 1.0, p = 
0.001), wound infection (RR = 1.03, 95%CI 1.00 to 1.05, p = 0.031), CVD (RR = 1.02, 95%CI 1.00 to  1.05, 
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p = 0.039), decreased incidence of Chylor’s leakage (RR = 0.98, 95%CI 0.96-0.99, p < 0.001), but no 
difference for the incidence of respiratory diseases or in-hospital mortality. The number of 
participants for each comparison were not reported. 
Higher BMI was associated with a 22% decrease in the relative risk of mortality (Highest vs lowest BMI 
RR 0.78, 95%CI 0.71 to 0.85, p<0.001) with no heterogeneity or publication bias detected. The pooled 
number of participants for each analysis was not reported. 
The authors concluded that high BMI was positively associated with the incidence of some post-
operative complications but that higher BMI was an independent prognostic factor for survival.  
Kayani et al. 2012 included 5 retrospective cohort studies of 1682 people, 3 of which were not included 
by Zhang et al. The AMSTAR score for this review was 4/11. This review also reported no formal 
assessment of study quality. This included 446 obese (BMI ≥30kg/m2) and 1236 non-obese patients 
with a mix of adenocarcinoma and squamous cell carcinoma who had undergone oesophagectomy. 
Meta-analysis found no effect of obesity on the completeness of surgical resection (2 studies 
n=640),post-operative mortality (5 studies n=1682), respiratory failure (4 studies n=1478) or rates or 
reoperation (3 studies, n=1250) all with no heterogeneity. There were non-significant trends towards 
a relationship between obesity and  rate of pulmonary embolism (4 studies, n=1478, OR 2.03, 95%CI 
0.94 to 4.39), p=0.07, I2=0%) and anastomotic leakage (5 studies, n=1682, OR 1.56, 95%CI 0.95 to 2.55, 
p=0.08 I2 42% not significant) with obese patients demonstrating higher rates of these events. 
Similar to the analysis of Zhang et al. (2013), there was a statistically significant relationship between 
obesity and long-term survival indicating better long term survival (22% decrease in the relative risk 
of mortality) in the obese group (3 studies, n=1196, HR 0.78 95%CI 0.64 to 0.96, p=0.02, I2=0%). 
Kayani et al. (2012) concluded that obesity alone does not increase risk of post-operative 
complications or mortality and that obesity may improve long term survival, though higher quality 
evidence is needed. 
The evidence for the relationship between obesity and post-operative complications following 
oesophagectomy   is somewhat inconsistent between these reviews. However both suggest a possible 
positive effect of obesity on survival rates. The GRADE level of evidence for this comparison is very 
low (downgraded for unknown limitations of studies, since not formal quality assessment was 
reported in either review). 
 
Colorectal cancer 
Outcome: mortality 
One review (Lee et al. 2015) investigated the association between pre- and post-diagnostic BMI with 
colorectal cancer-specific mortality and all-cause mortality in patients with colorectal cancer. 
They included 16 studies including a total of 58,917 people with colorectal cancer. The follow up 
period for these studies ranged from 4.9 to 20 years. The quality of included studies was assessed 
 Evidence review: lifestyle behaviours and outcomes for people living with and beyond cancer 
 
 
21 
 
F
IN
D
IN
G
S:
 D
IE
T
A
R
Y
 B
E
H
A
V
IO
U
R
 A
N
D
 O
B
E
SI
T
Y
 
using the Newcastle-Ottawa scale but the reports of this assessment are not reported in the review. 
The AMSTAR score for this review was 6/11. 
Pre-diagnosis, underweight was not associated with colorectal cancer-specific mortality but was 
associated with a 63% increase in the  relative risk of all-cause mortality (six studies, n for comparison 
not reported, RR 1.63, 95%CI 1.18 to 2.23, p<0.01). Pre-diagnosis overweight was not associated with 
cancer-specific or all-cause mortality. 
Pre-diagnosis obesity was associated with a 22% increased colorectal cancer-specific mortality (six 
studies, n for comparison not reported, RR 1.22, 95%CI 1.003 to 1.35, p<0.01) and all-cause mortality; 
number of studies and participants for comparison not reported, (RR 1.25, 95%CI 1.14 to 1.36, p<0.01).  
Post-diagnosis, underweight was associated with significantly increased all-cause mortality (10 
studies, n for comparison not reported, RR: 1.33, 95% CI: 1.20–1.47,p<0.01).  Post-diagnosis 
overweight was associated with significantly improved colorectal cancer-specific mortality (4 studies, 
n for comparison not reported RR: 0.84, 95% CI: 0.73–0.97,p<0.05) and all-cause mortality (number of 
studies and participants for comparison not reported, RR: 0.93, 95% CI: 0.86–0.997,p<0.05).  
Post-diagnosis obesity was significantly associated with an 8% relative increase  in all-cause mortality 
(number of studies and participants for comparison not reported, RR: 1.08, 95%CI: 1.03–1.13, p<0.01) 
while no association was found between post-diagnosis obesity and colorectal cancer-specific 
mortality. There was no suggestion of publication bias for any analyses. 
The review authors concluded that pre-diagnosis obesity and post-diagnosis underweight and are 
associated with increased risk of mortality whereas post-diagnosis overweight is associated with 
decreased all-cause mortality. The grade level of evidence for these associations is very low 
(downgrade for limitations as the quality of studies was not reported). 
 
Outcome QoL 
One review (Jansen et al. 2010) investigated quality of life among long term survivors of colorectal 
cancer (≥ 5 years from diagnosis). This review included 10 studies and explored a range of possible 
determinants of quality of life. The quality of included studies was assessed using the Mol 14 item 
checklist.  The AMSTAR score for this review was 4/11. The review found that higher BMI was 
associated with lower scores in physical functioning,, bodily pain, general health and vitality subscales 
of the SF-36, though psychological QoL was not associated with BMI. These findings arose from 2 
reports of one study of 259 female CRC survivors. The study was given a quality score of 12/14. No 
effect sizes were reported in this review. 
Using GRADE there is very low quality evidence (downgraded for imprecision due to inadequate 
reporting and results derived from a single study) that higher BMI is associated with lower quality of 
life scores on some subscales of the SF-36 tool. 
 Evidence review: lifestyle behaviours and outcomes for people living with and beyond cancer 
 
 
22 
 
F
IN
D
IN
G
S:
 P
H
Y
SI
C
A
L
 A
C
T
IV
IT
Y
 A
N
D
 E
X
E
R
C
IS
E
 B
E
H
A
V
IO
U
R
 
PHYSICAL ACTIVITY/ EXERCISE BEHAVIOURS 
 
Breast cancer  
Outcome: Mortality 
Seven systematic reviews (Barbaric et al 2010, Davies et al. 2011, Fontein et al. 2013, Ibrahim et al. 
2011, Kim et al. 2013, Lahart et al. 2015, Zhong et al. 2014) investigated the relationship between 
physical activity behaviours and mortality in people with breast cancer.   
The most recent of these (Lahart et al. 2015) included 22 prospective cohort studies with 123,574 
participants in total with a median follow up of eight years. The AMSTAR score for this review was 
7/11, the highest of the six reviews to investigate this topic. 
The quality of included studies was assessed using the Newcastle-Ottawa scale. Out of a maximum 9 
‘starts’ the mean quality score of included studies was 6 (range 4 to 8). 64% of studies were judged to 
not have controlled for known confounders adequately and only 41% of studies controlled for the 
influence of cancer stage and nodal status. 45% of studies were considered at risk of bias due to the 
degree of loss to follow-up or the completeness of statistical data. 
Meta-analysis was used to examine the relationship between PA and mortality comparing thhighest 
versus the lowest physical activity categories. The following comparisons were made (number of 
participants for each comparison were not reported in the review), with physical activity associated 
with a relative decrease in the risk of mortality for all comparisons:  
 
Lifetime pre-diagnosis PA and mortality 
All-cause mortality Hazard Ratio (HR) 0.82, 95%CI 0.70 to 0.96, I2 49%, 6 studies, n for comparison not 
reported 
Breast cancer related mortality: HR 0.73 95%CI 0.54 to 0.82, I2 67%, 5 studies, n for comparison not 
reported 
 
Recent pre-diagnosis physical activity and mortality 
All-cause mortality Hazard Ratio (HR) 0.73, 95%CI 0.65 to 0.82, I2 0%, 9 studies, n for comparison not 
reported 
Breast cancer related mortality: HR 0.84 95%CI 0.73 to 0.97, I2 0%, 11 studies, n for comparison not 
reported 
 
Post-diagnosis physical activity and mortality 
All-cause mortality: HR 0.52 95%CI 0.43 to 0.64 I2 54%, 8 studies, n for comparison not reported 
Breast cancer related mortality: HR 0.59 95%CI 0.45 to 0.78, I2 57%, 7 studies, n for comparison not 
reported  
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An analysis of the effect of meeting recommended physical activity guidelines post-diagnosis found 
the following effects: 
All-cause mortality: HR 0.54, 95%CI 0.38 to 0.76, I2 87%, 6 studies, n for comparison not reported 
Breast cancer related mortality: HR 0.67 95%CI 0.50 to 0.90, I2 73%, 7 studies, n for comparison not 
reported 
Physical activity post-diagnosis was associated with a greater risk reduction in all cause death in post-
menopausal survivors. However no clear pattern was found relating to the effect of ER and PR status. 
There was evidence suggestive of publication bias across all comparisons except lifetime recreational 
physical activity and both all-cause and breast cancer-related death.  
The review authors concluded that there are associations between pre and post-diagnosis physical 
activity levels and both all-cause and breast cancer specific mortality, but that effect estimates for 
these associations should be treated with caution due to evidence of heterogeneity.  Of the remaining, 
less recent reviews (Barbaric et al. 2010, Davies et al. 2011, Fontein et al. 2013, Ibrahim et al. 2011, 
Kim et al. 2013, Zhong et al. 2014) all concluded in agreement with the key findings of Lahart et al. 
(2015), of a relationship between higher levels of PA and reduced all-cause and breast cancer specific 
mortality with the exception of  Ibrahim et al. (2011) who found no statistically significant  difference 
between pre-diagnosis PA and breast cancer specific  mortality except in a subgroup of those with a 
BMI> 25kg/m2. However this analysis included only 2 studies compared to the inclusion of 11 studies 
in the more up to date review by Lahart et al. 
The GRADE level of evidence for these associations was rated as very low (downgraded variously for 
limitations, inconsistency (heterogeneity) and evidence of publication bias. 
 
Outcome: Recurrence and progression 
One review (Lahart et al. 2015) investigated the relationship between PA and breast cancer 
recurrence. This review found three studies and combined in their analysis studies which measured 
recurrence as an outcome with those which combined recurrence, progression and new primary 
breast cancers as one outcome. The included studies scored 6 or 7 out of a possible 9 on the quality 
assessment scale. 
i. Pre-diagnosis physical activity and progression/ recurrence 
HR 0.72 95%CI 0.56 to 0.91, I2 0% (2 studies, n for comparison not reported) 
ii. Post-diagnosis physical activity and progression/ recurrence 
HR 0.79 95%CI 0.63 to 0.98, I2 0% (2 studies, n for comparison not reported) 
Lahart et al. (2015) concluded that recreational physical activity is significantly associated with a lower 
risk of  breast cancer events.  The GRADE rating for these associations is rated as very low (downgraded 
for limitations of studies and risk of publication bias). 
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Outcome: cancer-related cognitive impairment 
One review (Henneghan et al 2016) investigated the effect of modifiable factors and cancer-related 
cognitive impairment in breast cancer survivors. The AMSTAR score for this review was 4/11. Of the 
factors investigated, physical activity/exercise was the only one relevant to this overview. Risk of bias 
was assessed using a 0-9 scale though the specific criteria are not reported. The review identified two 
small cross-sectional studies (combined n=55). The quality score of these studies was not reported. 
The results are described narratively.  One study reported that exercise moderated the negative 
effects of higher BMI on perceived cognitive impairments and one reported a statistically significant 
positive relationship (r=0.47, p=0.004) between self-reported exercise levels and cognitive 
impairment. The GRADE rating for these findings is very low, downgraded for (limitations due to 
unknown study quality). 
 
Prostate cancer 
Outcome: Mortality 
One review investigated the relationship between PA and survivorship in prostate cancer. The 
AMSTAR score for this review was 2/11. This review applied no formal quality assessment to included 
studies and described the findings of included studies narratively, with no meta-analysis performed. 
They identified one prospective study of 2686 men with a 4 year follow-up which found that those 
who engaged with >3 hours of Metabolically Equivalent Tasks (MET-h) of weekly activity following 
diagnosis reduced their risk of death (HR 0.65; 95% CI 0.52 to 0.82) from any cause and a nonsignificant 
reduction in risk of prostate cancer death (H 0.88, 95% CI 0.52 to 1.49) when compared with those 
who did less than 3MET-h of weekly activity. 
More vigorous activity, and longer duration of activity, were associated with further reductions in risk 
for all-cause mortality. The review authors concluded that the findings are indicative of a benefit of 
physical activity in terms of prostate cancer/and overall mortality and that there appears to be a dose 
gradient for this relationship. The GRADE rating for this association is very low (downgraded for 
unknown limitations of studies). 
 
Colorectal cancer 
Outcome: Mortality 
The same review Davies et al. (2011) investigated the relationship between PA and survivorship in 
colorectal cancer and identified two prospective observational studies of 1342 participants with a 
diagnosis of colorectal cancer.  
One study (n=526) with a 5.5 year follow up found that self- reported leisure time physical activity at 
least, once per week was associated with reduced disease specific mortality (HR 0.73, 95% CI 0.54 to 
1.00, p value not reported). This benefit was greater in a subgroup of participants with stage II – III 
tumours (HR 0.49; 95% CI 0.30 to 0.79). 
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One study (n= 816) followed stage III colon cancer participants up for 6 months following post-
operative adjuvant chemotherapy. They report that physical activity was associated with improved 
disease-free survival but the overall effect size was not reported in this review. In a subgroup analysis 
of females, the effect size was HR 0.33, 95%CI 0.11 to 0.99, p=0.046. In males it was HR 0.89, 95% CI 
0.44 to 1.78, p= 0.3.  Barbaric et al (2010), also included studies investigating this relationship and 
included the same studies. They also concluded that there was evidence of an association between 
physical activity and survival but that these results should be interpreted with caution.  
The GRADE rating for these associations is very low (downgraded for unknown limitations of studies, 
imprecision due to uncertain statistical significance and focus on subgroup analyses). 
 
Endometrial cancer 
Outcome: Quality of Life 
One review (Koutoukidis et al. 2015) explored the associations between physical activity and health 
related quality of life in survivors of endometrial cancer. The AMSTAR score for this review was 6/11. 
Study quality was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) checklists. 
This review included three relevant cross-sectional studies (combined n 706) though details of the 
characteristics of these studies was only provided for two of them and the quality assessment results 
for only one of them.  
No meta-analysis was reported.   Across HRQoL domains there was inconsistency in the statistical 
significance of effects, though the authors report that the direction of observed effect was consistently 
towards a benefit of meeting physical activity guidelines. Effect sizes, expressed as standardised mean 
difference (Cohen’s d) ranged from small to moderate. 
The authors conclude that being physically active correlates with an improved quality of life in this 
group of cancer patients. However the inconsistency of statistically significant effects, combined with 
the incomplete reporting of study details and study quality on this review lead to a GRADE rating of 
very low for this comparison (downgraded for limitations, imprecision and inconsistency). 
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SMOKING BEHAVIOURS 
 
Lung cancer 
Three reviews (Parsons et al. 2010, Rowland et al. 2012, Zhang et al. 2015) examined the relationship 
between smoking behaviours and outcomes in people with lung carcinomas. 
 
Outcome: Survival and recurrence 
One review (Parsons et al. 2010) reviewed the evidence that smoking cessation after diagnosis of a 
primary lung tumour affects prognosis. They included studies of people with a diagnosis of lung cancer 
at any stage with the outcomes of all-cause mortality and recurrence. The definition of smoking 
cessation was not clearly defined.  
This review identified 10 observational cohort studies (4 prospective, 5 retrospective and one unclear) 
with 1929 participants. Study quality was assessed with the Altman criteria and scores ranged from 5 
to 9 out of 11 points. In all but one study patients presented with early stage lung cancer and so the 
results largely reflect the possible impact of cessation in that group. 5 studies were in non-small cell 
lung cancer and 5 in small cell lung cancers and these groups were analysed separately. 
Four studies with 460 participants with non-small cell carcinoma were meta-analysed with unadjusted 
estimates and demonstrated a non-statistically significant 19% increase in the risk with continued 
smoking with no heterogeneity (HR= 1.19 (95%CI 0.91-1.54) I2 = 0%). 
Two studies with 278 people with small cell carcinoma were pooled. Unadjusted estimates 
demonstrated a non-statistically significant 18% increase in the risk with continued smoking with no 
heterogeneity (HR = 1.18 (95%CI 1.03-1.36), I2 = 0%). 
Estimates with adjustment for key prognostic variables, derived from single studies, were presented 
and demonstrated larger effect sizes (non-small cell, one study n=204, HR 2.94 (95%CI 1.15 to 7.54); 
small cell, one study n=186, HR = 1.86 (95%CI 1.33-2.59). 
In in non-small cell cancer adjusted and unadjusted estimates from a single small study (n= 35) did not 
show an increase in second primary tumours associated with continued smoking. However one study 
showed an 86% increase in recurrence with continued smoking (HR 1.86, 95%CI 1.01to 3.41, n=204). 
In small cell cancers continued smoking was associated with an increase in second primary cancers 
with both unadjusted (3 studies, n= 518, HR 1.86, 95%CI 0.96 to 3.60, I20%) and adjusted estimates (1 
study, n=64 HR 4.31, 95%CI 1.09 to 16.98). 
One study (N=186) showed an increase in recurrence in small cell carcinoma with continued smoking 
(HR 1.26, 95%CI 1.06 to 1.50). 
The review authors concluded that there is preliminary evidence that smoking cessation after 
diagnosis improves prognosis and that offering smoking cessation to this group may be beneficial.  
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 The GRADE rating for these associations is there is low quality evidence that continued smoking is 
associated with increased all-cause mortality in lung cancer and very low quality evidence 
(downgraded for imprecision as non-statistically significant or based on single studies) that continued 
smoking post diagnosis is associated with increased cancer recurrence. 
Zhang et al. (2015) investigated the relationship between smoking and response to treatment with 
epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors in advanced non-small cell lung 
cancer EGFR-mutant patients and reported progression free survival as an outcome. They identified 9 
studies (2 prospective and 7 retrospective) of 1029 participants.  Study quality was assessed using the 
Quorum and Cochrane collaboration guidelines but the results of this assessment were not reported. 
This review had an AMSTAR score of 4/11. 
Comparing those who had ever smoked with those who had never smoked, meta-analysis of 9 studies 
n= 1029 reported a 27% reduction in progression free survival in ever smokers (HR 0.73, 95%CI 0.60 
to 0.88), I2=0%). There is very low quality evidence (downgraded for unknown quality of studies) that 
having ever smoked is associated with a decrease in progression-free survival in advanced non-small 
cell lung cancer EGFR-mutant patients treated with epidermal growth factor receptor (EGFR) –tyrosine 
kinase inhibitors. 
  
Outcome: Quality of Life 
One review (Rowland et al. 2012) investigated the differences in HRQoL between patients with lung 
cancer who smoke and those who have quit smoking or never smoked. This review had an AMSTAR 
score of 5/11. They identified 8 studies including 2,100 participants, 5 of which were cross-sectional 
and 3 longitudinal in design. Study quality was assessed using the CASP appraisal tool. The authors 
judged all studies to be “methodologically sound” with scores ranging from 7 to 10 out of a maximum 
12. 
No meta-analysis was conducted and results were summarised narratively. Four studied found no 
difference in overall HRQoL dependant on smoking status. Two studies demonstrated lower HRQoL  
in smokers compared to never smokers, with one study (n=1019) showing that the scores of those 
who quit smoking and did not resume were closer to those of never smokers than current smokers. 2 
studies found lower scores on subscales of HRQoL in current smokers. In one longitudinal study 
(n=438) current smokers reported worse HRQoL than former smokers who reported worse HRQoL 
than never smokers at less than 3 years and more than 5 years following diagnosis. Effect sizes were 
not presented for any of these comparisons. 
The authors of the review concluded that smoking is associated with lower HRQoL in lung cancer 
patients. The GRADE quality of evidence for this association is very low (downgraded for 
inconsistency). 
Breast cancer 
Outcome: Survival 
One review (Braithewaite et al. 2012) investigated the association between smoking and breast cancer 
mortality. This review included 7 cohort studies, including their own study, of adult women with 
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invasive breast cancer. Sample sizes ranged from 528 to 604,412 participants. No assessment of study 
quality was reported. This review had an AMSTAR score of 3/11. 
No meta-analysis was conducted. Four of seven studies found a significant increase in breast cancer 
related death in current versus never smokers. There was little evidence of an increase in breast 
cancer mortality in former smokers compared with never smokers. For those studies that found an 
association effect sizes ranged from  a 43% increase in the relative risk of breast cancer related death 
(RR 1.43, 95%CI 1.24 to 1.65) to a twofold increase in relative risk (HR 2.01, 95%CI 1.27 to 3.18). Three 
studies showed no significant association. 
The authors conclude that there is a positive association between current smoking and breast cancer 
mortality, but that the evidence for an effect of former smoking is very weak. The GRADE quality of 
evidence for these associations is very low (downgraded for inconsistency and the unknown quality 
of the included studies). 
 
Liver cancer 
One review (Pang et al. 2015) investigated the effect of smoking liver cancer mortality. Within this 
review they included 4 studies (one prospective, 3 retrospective) relevant to this overview which 
evaluated the effect of smoking on people with a diagnosis of hepatocellular carcinoma (HCC). Study 
quality was assessed using the Newcastle-Ottawa scale and scores for the relevant studies ranged 
from 6 to 8 out of 9. This review has an AMSTAR score of 7/11. 
Outcome: Survival 
Pooling of studies did not demonstrate a statistically significant relationship between smoking status 
and overall survival (3 studies, pooled n= 729) HR 1.90, 95%CI 0.84 to 4.30, I2 87%) or recurrence free 
survival (2 studies, pooled n=286, HR 1.75, 95%CI 0.87 to 3.53, I2 54.4though there was substantial 
heterogeneity for both analyses. Sensitivity analyses using a fixed effect statistical model showed a 
significant association for both outcomes. 
Outcome: Recurrence 
One study (n=304) found that smoking was associated with an increased recurrence (HR 1.40, 95%CI 
1.12 to 1.74). 
Then authors of the review concluded that smoking was associated with post-operative recurrence in 
liver cancer but was not a useful predictor of overall or recurrence-free survival.  Using GRADE, there 
is very low quality evidence that smoking is associated with a higher rate of recurrence in people with 
HCC (downgraded for imprecision as single study). 
Colorectal cancer 
One review (Walter et al. 2014) investigated the effect of smoking on survival in colorectal cancer 
(CRC) patients. This review had an AMSTAR score of 6/11.  The review included 16 studies with 62,278 
participants. Study designs were not reported.  
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Study quality was assessed using a 4 point tool based on the Meta-analysis of observational studies in 
epidemiology (MOOSE) checklist. Scores ranged from 1 to 4. Meta-analysis only included studies with 
a score range  2-4. 
This review found no effect of former smokers (compared to never smokers) on all-cause mortality in 
a random effects model meta-analysis (4 studies, n= not reported for this analysis) , though a  fixed 
effect model suggested a 15% increase in mortality in former smokers (HR 1.15, 95%ci 1.01 to 1.31) 
with low heterogeneity. 
Current smoking (compared with never smoking) was associated with a relative increased in all-cause 
mortality of 26% (6 studies, n not reported for this analysis. HR 1.26,95%CI 1.15 to 1.37, I2 35.2%) in a 
random effects meta-analysis. Across individual studies around half demonstrated no statistically 
significant association. 
Of three studies that analysed the group ‘ever smokers’ all showed effects or trends towards a 
significant effect of smoking on mortality and survival, favouring never smokers. Of five studies that 
assessed the relationship between smoking intensity (measured in pack-years or cigarettes per day) 
and mortality or recurrence free survival a positive dose-response relationship could be seen though 
a number of the effect estimates this was based on were not statistically significant. 
The authors conclude that the results support the existence of detrimental effects of smoking after 
CRC diagnosis. Using GRADE there is very low quality evidence of an association with current smoking 
and all-cause mortality (downgraded for unclear limitations of studies, inconsistency and imprecision). 
 
Renal cancer 
One review (Xu et al 2014) investigated the impact of smoking and survival in patients with renal cell 
carcinoma (RCC). This review had an AMSTAR score of 5/11.The review included 14 studies including 
343,993 patients with RCC, but did not report the study designs. Methodological quality was assessed 
using the Newcastle-Ottawa scale and scores ranged from 5 to 9 out of 9. 
Outcome: SurvivalMeta-analysis included subgroup analyses separating current from former smokers. 
These demonstrated a 57% relative increase overall mortality in current vs never smokers (3 studies, 
n for analysis not reported, HR 1.57, 95%CI 1.20 to 2.06, I2 31.6%), but no significant increase in former 
smokers vs never smokers (2 studies, n for analysis not reported HR 1.14, 95%CI 0.79 to 1.53). 
Similarly or disease specific mortality current smokers had a 50% increase in overall mortality 
compared with never smokers (HR 1.50, 95%CI 1.10 to 2.05, 4 studies, n for analysis not reported)  but 
no significant effect was observed for former smokers (HR 0.98, 95%CI 0.72 to 1.34, 3 studies, n for 
analysis not reported). 
In terms of survival current but not former smoking was associated with poorer overall survival (HR 
2.70, 95%CI1.70 to 4.29, one study, n for analysis not reported) and progression free survival (HR 2.94, 
95%CI 1.89 to 4.58, one study, n for analysis not reported).  Finally a history of smoking (current and 
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former smokers) was associated with a 1% relative difference in overall survival with no heterogeneity 
(HR 1.01, 95%CI 1.00 to 1.02, I2 0%). 
The authors concluded that current smoking is associated with poorer survival in patients with RCC. 
Using grade the quality of the evidence for this association is very low (downgraded for limitations of 
studies as the designs are unclear). 
 
Urothelial cancer 
One review (Crivelli et al. 2014) reviewed the evidence regarding the impact of smoking status or 
exposure on recurrence, cancer specific and any-cause mortality in patients with urothelial carcinoma 
(UC) treated surgically. They included no assessment of study quality. This review had an AMSTAR 
score of 4/11. 
The review included 29 studies but did not clearly report the study designs. No meta-analysis was 
conducted and results were synthesised narratively. Synthesis largely took a “vote counting” approach 
quantifying the number of studies that found significant relationships for key comparisons. 
Findings of significant associations between smoking status or exposure and key outcomes were 
inconsistent across studies regardless of the surgical management approach. The majority of studies 
demonstrated an association of smoking status and exposure with recurrence following transurethral 
resection of the bladder (TURB).  
The authors concluded that smoking may lead to less favourable outcomes for patients with UC of the 
balder and upper tract. Using GRADE the quality of evidence is very low (downgraded for limitations 
of studied due to unknown study design and quality and inconsistency). 
 
Head and neck cancer 
Outcome HRQoL 
One review (So et el. 2012) investigated the determinants of quality of life among head and neck 
cancer survivors at one year after treatment. The review explored a broad range of possible 
determinants. This review had an AMSTAR score of 4/11. Methodological quality was assessed using 
a 14 item checklist. 
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This review included one prospective longitudinal study of 316 participants that demonstrated that 
smoking in the previous 2 months was predictive or poor QoL scores on all items of the SF-36 scale 
except the role-emotional functioning subscale. This study scored 11/14 and was rated by the review 
authors as of high quality. No effect size was reported. Using GRADE there is very low quality evidence 
(downgraded for imprecision due to inadequate reporting and results derived from a single study) that 
smoking is associated with lower quality of life in head and neck cancer survivors. 
 
All cancers 
One review (Florou et al. 2014) reviewed the evidence of association between smoking and survival, 
treatment effectiveness, second primary tumours and quality of life in people with any form of cancer. 
This review scored 3/11 on the AMSTAR scale. The review included 20 studies (4 retrospective 
observational, 15 prospective observational and 3 randomised trials) but presented no formal 
assessment of study quality. No meta-analysis was conducted and results were synthesised 
narratively. 
The majority of studies identified were in smoking-related cancers such a lung, bladder and head and 
neck cancer. Following a descriptive review of the included studies the authors conclude that 
continued smoking after cancer diagnosis is related to reduced treatment efficacy, survival and 
increased risk for second primary malignancies and deterioration of quality of life. The descriptive 
nature of the reporting of this review precludes GRADE assessment for specific comparisons. 
 
ALCOHOL–RELATED BEHAVIOURS 
 
Breast cancer 
One review (Gou et al. 2013) investigated the relationship between alcohol consumption and breast 
cancer survival and recurrence. This review had an AMSTAR score of 5/11 and included 25 cohort 
studies including 719,555 breast cancer survivors. No formal assessment of study quality was 
reported. 
Meta-analysis  comparing highest versus lowest consumption  demonstrated no significant association 
between alcohol intake and breast cancer mortality (25 studies, pooled n not reported, HR 1.06, 95%CI 
0.97 to 1.17, I2 31%)  or recurrence (5 studies, pooled n not reported HR 1.21, 95%CI 0.895 to 1.53, I2 
0%). Similarly no association was seen in an analysis of post-diagnosis consumption. Subgroup analysis 
by oestrogen receptor status or menopausal status demonstrated no difference in mortality. 
 In a subgroup of premenopausal participants an association was seen between alcohol consumption 
and recurrence (2 studies, n for analysis not reported, HR 1.52, 95%CI 1.21 to 1.90, I20%). The authors 
report that subgroup analysis of levels of alcohol consumption showed an apparent dose-response 
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relationship for mortality and recurrence though the evidence for this is questionable with only one 
dose subgroup (>20g/day) showing a statistically significant effect and only on mortality. 
The review authors conclude that alcohol drinking was not associated with increased breast cancer 
recurrence or mortality but based on the purported dose response relationship breast cancer patients 
should avoid drinking >20g/day. Using GRADE there is low quality evidence that alcohol consumption 
is not associated with mortality or recurrence in breast cancer. 
 
Head and neck cancer 
Outcome HRQoL 
One review (So et el. 2012) investigated the determinants of quality of life among head and neck 
cancer survivors at one year after treatment. The review explored a broad range of possible 
determinants. This review had an AMSTAR score of 4/11. Methodological quality of the included 
studieswas assessed using a 14-item checklist. 
This review included one prospective longitudinal study of 316 participants that found no influence of 
alcohol consumption on QoL . This study scored 11/14 and was rated by the review authors as of high 
quality. Using GRADE there is very low quality evidence (downgraded for imprecision due to 
inadequate reporting and results derived from a single study) that alcohol consumption is not 
associated with QoL in head and neck cancer survivors. 
 
Upper aerodigestive tract cancer 
One review (Druesne-Pecollo et al. 2013) investigated the association between alcohol drinking with 
second primary cancer risk in patients with upper aerodigestive tract (UADT) cancers, including those 
of the oral cavity, pharynx, larynx and oesophagus. 
This review had an AMSTAR score of 6/11. It included 19 studies of which 8 were cohort studies and 
11 case-control studies. No formal assessment of study quality was reported. 
Outcome: UADT second primary cancer 
Comparing highest to lowest alcohol intake, alcohol intake was associated with an almost 2-
foldincrease in the risk of a second primary UADT cancer (10 studies, 6385 participants, RR 2.97 95%CI 
1.96 to 4.50, p-0.001, I231.3%) with no evidence of small study bias. In a dose response relationship 
analysis (2 studies, 3614 participants) the relative risk increased by 9% with every 10 gram/ day 
increase in alcohol consumption (RR 1,09, 95%CI 1.04 TO 1.14, p=0.001). 
Outcome: UADT and lung second primary cancer 
Comparing highest to lowest alcohol intake, alcohol intake was associated with a 91% relative increase 
in the risk of second primary UADT or lung cancer (7 studies, 3720 participants, RR 1.91, 95%CI 1.17 
TO 3.13, p=0.01, I2 58%) with heterogeneity, but no evidence of small study bias. Subgroup analyses 
showed that studied adjusted for age, gender and smoking tended to report weaker associations and 
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that the association was significant for studies conducted in the USA, studies assessing consumption 
by interview, studies comparing drinkers to non-drinkers, studies not exclusively examining 
metachronous second primary cancers and case-control but not cohort studies. 
A positive association was also found comparing highest to lowest alcohol intake on all-site second 
primary cancers with no heterogeneity or evidence of small study bias (6 studies, 4267 participants, 
RR 1.60, 95%CI 1.22 to 2.10, I2 4.4%). 
The authors conclude that alcohol drinking is associated with an increased risk of second primary 
cancers. The GRADE rating for this association is low (downgraded once for limitations due to 
unknown quality of included studies, upgraded once for consistency and dose-response relationship).
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Discussion 
 
SUMMARY OF KEY FINDINGS 
 
Dietary behaviours and obesity 
There is very low quality evidence that: 
 Higher soy consumption may be associated with lower mortality and recurrence in people 
following breast cancer diagnosis 
 Green tea consumption may be associated with lower recurrence in people following breast 
cancer diagnosis 
 Low fat diet is not associated with all-cause mortality in people following breast cancer 
diagnosis. 
 Obesity is associated with lower quality of life in people following endometrial cancer 
diagnosis. 
 Obesity is associated with higher mortality and risk of recurrence in people following prostate 
cancer diagnosis. 
 Higher BMI is associated with an increase in specific post-operative complications in people 
undergoing surgical treatment of oesophageal cancer but is associated with better survival 
rates. 
 Pre-diagnosis obesity and post-diagnosis underweight are associated with increased risk of 
mortality, while post diagnosis overweight is associated with decreased mortality in people 
with colorectal cancer. 
 Higher BMI is associated with lower quality of life on some quality of life subscales in colorectal 
cancer. 
 
Physical activity and exercise behaviour 
There is very low quality evidence that: 
 Pre and post-diagnosis physical activity levels are associated with lower all-cause and cancer 
specific mortality, recurrence and disease progression in people with breast cancer. 
 More vigorous physical activity is associated with reduced all-cause and cancer specific 
mortality in men with a diagnosis of prostate cancer. 
 Higher levels of physical activity are associated with lower cancer specific mortality/ disease 
free survival in people with colorectal cancer. 
 Being physically active is associated with higher quality of life in people with endometrial 
cancer. 
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Smoking related behaviours 
There is very low quality evidence that: 
 Smoking cessation after diagnosis is associated with improved prognosis in people with lung 
cancer. 
 Continued smoking is associated with increased all-cause mortality and increase risk of 
disease recurrence in people following lung cancer diagnosis. 
 Smoking is associated with lower HRQoL in people with lung cancer and head and neck cancer. 
 Current smoking is associated with higher breast cancer related mortality. 
 Smoking is associated with a higher risk of recurrence in people with a history of liver cancer 
but is not a useful predictor of survival. 
 Current smoking is associated with higher all-cause mortality in people with colorectal cancer 
and renal cancer, and less favourable outcomes in urothelial cancer. 
 
Alcohol related behaviours 
There is very low quality evidence that: 
 Alcohol drinking is not associated with increased breast cancer recurrence or mortality. 
 Alcohol consumption is not associated with quality of life in head and neck cancer survivors. 
There is low quality evidence that: 
 Alcohol consumption is associated with an increased risk of second primary cancers in people 
diagnosed with upper aerodigestive tract cancer. 
 
Completeness of the included evidence 
In terms of volume of systematic reviews more reviews have been published relating to breast cancer 
than for other forms of cancer, particularly in relation to dietary and physical activity related 
behaviours. In terms of behaviours across a number of cancer types, there were numerous reviews 
for dietary, physical activity and smoking behaviours but the review evidence for other behaviours 
was either piecemeal or absent. Predictably most reviews of smoking behaviours specifically for 
people with a diagnosis of lung cancer. Other cancers were more poorly represented. The lack of 
review evidence identified for other cancers and behaviours is not a direct measure of the amount of 
available evidence on those topics, although the lack of review conducted may in part reflect a tacit 
knowledge in the research community of the paucity of primary literature. Additionally it may also 
reflect the relative rarity of those cancers with low coverage in this overview. 
Due to the way most reviews were conducted and reported it was not possible to clearly stratify the 
results by the stage in the cancer journey of various populations. The majority of reviews took a broad 
approach, including people post-diagnosis or post-cancer treatment. 
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Quality of the included evidence 
The evidence for all findings was rated as low or more commonly very low using the GRADE approach 
(Guyatt et al. 2008). In the GRADE approach evidence from non-randomised studies starts with a rating 
of “low quality” and may then be up or downgraded on a number of different criteria. For most 
comparisons evidence was downgraded from “low” to "very low” on the basis of imprecision, 
inconsistency or limitations in the included studies. Where an included review did not conduct or 
report a formal assessment of the quality of the included evidence we downgraded that evidence for 
limitations in the included studies. Common reasons for upgrading observational data are where 
effect sizes or associations are large and consistent or where a clear dose-response relationship was 
observed, but those features were not commonly present in the reviewed evidence. 
It is arguable that GRADE lacks some discriminatory value for evaluating the quality these types of 
data. However it is well accepted that observational data carry a high risk of potential confounding. 
While 'very low' is the lowest judgement that can be made in the GRADE system, where some evidence 
exists, such a judgement indicates that there are numerous sources of potential bias that might explain 
the observed effects. It is notable that the majority of the included reviews recommended caution in 
interpreting the observed associations.  
The majority of associations were presented as odds ratio, risk ratios or hazard ratios. These effect 
sizes represent the relative rather than absolute difference in risk and as such can give estimates of 
the difference in risk that appear more dramatic than they are in reality. So in instances where the 
baseline risk for an event is low, a large relative increase or decrease in the risk may still represent a 
small difference in real terms. 
At the review level, the quality of reviews measured using the AMSTAR tool was generally low with a 
median score of 4/11. Many of the included reviews omitted fundamental aspects of good practice in 
systematic review methods such as assessing the quality of the included studies and few searched for 
grey literature, raising the risk that important evidence may have been missed. The universal lack of 
pre-registration of review protocols on PROSPERO also raises the risk of post-hoc alterations in the 
approach taken to data synthesis, which also introduces a potential bias.  It should be noted that the 
AMSTAR assessment effectively assesses the quality of reporting rather than directly measuring the 
quality of review conduct. In some cases reviews may be disadvantaged by the limitations on full and 
thorough reporting imposed by a journal's publishing requirements. 
It is important to note that obesity and BMI are not lifestyle behaviours. We included them in this 
overview as we felt they were factors that are partially associated with lifestyle behaviours of diet and 
physical activity. However we recognise that they arenot always easily modifiable. It is also recognised 
that BMI has important limitations. In tends to overestimate adiposity in those with a more lean body 
mass  and does not adequately account for variations in physical build (Nuttall 2015). 
It is also important to recognise that many lifestyle behaviours are measured using self-report indexes 
and as such as prone to inaccuracy through recall bias and misreporting, particularly when behaviours 
are associated with cultural beliefs relating to virtue and good health (Short et al. 2009). 
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Strengths and Limitations of the overview process 
The comprehensive search strategy ensures that this overview represents a comprehensive summary 
of all existing eligible systematic reviews in the English language published prior to the search dates 
and the pre-publication of our protocol on PROSPERO ensures methodological transparency and 
militates against potential post-hoc decision making which can introduce bias to the process.  Dual 
screening of searches and data extraction and independent quality assessment of included reviews 
ensured a rigorous process. 
Taking published systematic reviews as the sole evidence increases the potential risk of publication 
lag, wherein possible important new evidence that has not yet been included in published systematic 
reviews is not identified and included. The included reviews used a range of different methodological 
quality and risk of bias assessment tools, or none. Given that we relied primarily on the quality and 
bias judgements of the included reviews, and did not systematically apply a standard risk of bias tool 
to each original study, it is possible that important sources of potential bias may have been missed. 
The restriction to only included English language reviews led to the exclusion of one review of diet and 
physical activity in colorectal cancer (Perez-Cueto et al. 2011) which is a topic area covered by our 
included reviews. 
The use of the GRADE criteria introduces an element of subjective judgement. It was also found to be 
more difficult when we were primarily assessing the included reviews rather than the original studies, 
all of which assessed and reported study quality in different ways. A consistent approach to  
judgements across the different interventions has been applied but it should be recognised that these 
judgements are open to interpretation.  
 
Changes between the review protocol and the final review. 
Our initial protocol included the use of recreational drugs as an included lifestyle behaviour. We 
removed the use of recreational drugs from the list of included, lifestyle choices. This arose from a 
decision taken between the research team and the funding body prior to the conduct of any searches 
for this review as it was considered that the practical difficulties of sensitively searching for this 
evidence in an already broad review or reviews, and the likely quality of the available data suggest 
that this topic might be better answered by a separate, focused systematic review of original studies. 
This amendment was made to the PROSPERO record prior to the searches. 
 
Implications for practice 
While the evidence is low to very low the majority of findings in this review seem well aligned with 
accepted public health messages relating to the benefits of physical exercise, weight control and 
smoking cessation. The evidence related to alcohol consumption is more limited. It is interesting that 
current smoking appears more consistently associated with undesirable outcomes than former 
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smoking or ever smoking, perhaps suggesting that encouragement to quit smoking remains a positive 
message at any stage in the cancer journey. 
While obesity appears to be related to post-operative complications in cancers of the gastro-intestinal 
tract, it should also be borne in mind that higher BMI appears to be associated with higher survival 
rates in this group and that underweight may be a risk for higher mortality, suggesting that a more 
nuanced message is possible in this group regarding weight control and diet and that it is important 
to discriminate between healthy and unhealthy levels of low weight. 
  
Implications for research 
The available evidence demonstrates that some behaviours may be associated with important 
outcomes in people living with and beyond cancer. However it does not inform us of whether 
specifically delivering interventions aimed at modifying those behaviours are effective. For that to be 
the case interventions must be first successful at altering the desired behaviour to the necessary 
extent and in a reliable fashion, and then change in that behaviour must be effective in altering the 
outcomes of interest. It should not be assumed that either  of these requirements are inevitable. The 
effectiveness of interventions aimed at altering lifestyle behaviours for improving outcomes for 
people living with and beyond cancer is beyond the scope of this overview but is the core aim of an 
overview being conducted alongside this one (currently in process). 
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APPENDIX A   Ovid Medline Search Strategy 
 
1. MeSH descriptor: [neoplasms] explode all trees) 
2. Lifestyle OR healthy OR exercis* OR fit* OR active*OR diet* OR eating* OR smok* OR sedentar* OR 
tobacco OR drink* OR alcohol* OR nutrit*.ab.ti 
3. meta-analysis.pt. 
4. meta-analysis.sh. 
5. (meta-analys* or meta analys* or metaanalys*).tw,sh. 
6. (systematic* adj5 review*).tw,sh. 
7. (systematic* adj5 overview*).tw,sh. 
8. (quantitativ* adj5 review*).tw,sh. 
9. (quantitativ* adj5 overview*).tw,sh. 
10. (quantitativ* adj5 synthesis*).tw,sh. 
11. (methodologic* adj5 review*).tw,sh. 
12. (methodologic* adj5 overview*).tw,sh. 
13. (integrative research review* or research integration).tw. 
14. OR/ 3-13 
15. 1 AND 2 AND 14 
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APPENDIX B   Reasons for study exclusions 
Review Reason for exclusion 
Albrecht et al. 2012 Review of interventions 
Albuquerque et al. 2014 Not specific to the population of interest 
Ali et al. 2014 Not a systematic review 
Arden-Close et al. 2010 Not a systematic review 
Arem et al. 2013 Not a systematic review 
Asemi et al. 2015 Not specific to the population of interest 
Azim et al. 2011 Not a systematic review 
Ballard-Barbash et al. 2011 Not a systematic review 
Barber et al. 2012 Does not include relevant lifestyle behaviours 
Bellury et al. 2011 Not a systematic review 
Biswas et al. 2015 Not specific to the population of interest 
Boje et al. 2014 Does not include relevant lifestyle behaviours 
Buffart et al. 2014 Not a systematic review 
Burris et al. 2015 Does not include outcomes of interest 
Butow et al. 2012 Does not include relevant lifestyle behaviours 
Cai et al. 2014 Not specific to the population of interest 
Cannioto et al. 2013 Not a systematic review 
Cemal et al. 2013 Does not include relevant lifestyle behaviours 
Charlette et al. 2013 Not a systematic review 
Chlebowski et al. 2013 Not a systematic review 
Craft et al. 2010 A review of interventions 
Duijts et al. 2014 Does not include relevant lifestyle behaviours 
Eakin et al. 2015 Not a systematic review 
Ernst et al. 2012 Does not include relevant lifestyle behaviours (supplements) 
Golabek et al. 2014 Not specific to population of interest 
Goodwin et al. 2010 Not a systematic review 
Hamaker et al. 2014 Does not include relevant lifestyle behaviours 
Hasegawa et al. 2015 Not a systematic review 
Hasenoehrl et al. 2015 A review of interventions 
Hauner et al. 2011 Not a systematic review 
Hori et al. 2011 Not a systematic review 
Islami et al. 2014 Not specific to the population of interest 
Je et al. 2013 Not a systematic review 
Jiang et al. 2015 Not specific to population of interest 
Jones et al. 2013 Not a systematic review 
Jones et al. 2011 Does not include the outcomes of interest. 
Jun et al. 2012 A review of interventions 
Kampman et al. 2012 Not a systematic review 
Keogh et al. 2012 A review of interventions 
Knobf et al. 2011 Not a systematic review 
Kwan et al. 2011 Not a systematic review 
Kwan et al. 2011 A review of interventions 
Lassig et al. 2012 Not a systematic review 
Lee et al. 2012 Not a systematic review 
Leone et al. 2013 An interventions review. 
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Li et al. 2013 Not specific to the population of interest 
Li et al. 2014 Not specific to the population of interest 
Lis et al. 2012 Not a systematic review 
Liu et al. 2015 Not specific to the population of interest 
Lof et al. 2012 Not a systematic review 
Lonbro et al. 2014 Does not include outcomes of interest 
Loprinzi 2012 Not a systematic review 
Loprinzi et al. 2014 Not a systematic review 
Ma et al. 2015 Not specific to the population of interest 
Makarem et al. 2013 Not a systematic review 
Malerba et al. 2013 Not specific to the population of interest 
Mandair et al. 2014 Not specific to the population of interest 
Masko et al. 2013 Does not include outcomes of interest 
Mazzarino et al. 2015 A review of interventions 
Millar et al. 2012 Not a systematic review 
Mishra et al. 2015 A review of interventions 
Nelson et al. 2013 Not specific to the population of interest 
Noguchi et al. 2015 Not a systematic review 
Okamoto et al. 2012 Not a systematic review 
O’Rorke et al. 2010 Not specific to the population of interest 
Paramanandam et al. 2015 A review of interventions 
Perez-Cueto et al. 2011 Not in English language 
Pierce et al. 2014 Not a systematic review 
Proper et al. 2011 Not specific to the population of interest 
Qin et al. 2014 Not a systematic review 
Rafie et al. 2015 Not specific to the population of interest 
Rehm et al. 2010 Not specific to the population of interest 
Reynolds et al. 2011 Not a systematic review 
Rossi et al. 2014 Not a systematic review 
Schmid et al. 2014 Not a systematic review 
Secord et al. 2016 Not a systematic review 
Shi et al. 2015 Not a systematic review 
Stolley et al. 2010 Not a systematic review 
Storic et al. 2013 A review of interventions 
Szymlek-Gay et al. 2011 Not a systematic review 
Tarraga Lopez et al. 2014 Not a systematic review 
Van Blarigan et al. 2015 Not a systematic review 
Van Meer et al. 2013 Not a systematic review 
Vance et al. 2011 Not a systematic review 
Vijayvergia et al. 2015 Not a systematic review 
Wang et al. 2012a Not specific to the population of interest 
Wang et al. 2012b Not specific to the population of interest 
Wang et al. 2011 Not a systematic review 
Wang et al. 2014 Not specific to the population of interest 
Weikert et al. 2010 Not a systematic review 
Wooding et al. 2014 Not a systematic review 
Xue et al. 2012 Not a systematic review 
Zaman et al. 2012 Not specific to the population of interest 
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